Company Monitoring Page for Novartis

latest headlines for company on cafepharma

7 Pharma Stocks Near 52-Week Highs
Motley Fool
Sat, 10/30/10 - 12:43 pm
Tags:
JNJ, Novartis, Merck, Abbott Laboratories, AstraZeneca, Novo Nordisk
Novartis Wins Challenge Against J&J Over Its French Contact Lens Patent
Bloomberg
Thu, 10/28/10 - 09:47 am
Tags:
France, JNJ, Novartis, patents, contact lens
Should Investors Take A Chance On Savient?
Investopedia
Tue, 10/26/10 - 11:50 am
Tags:
Savient, Krystexxa, Bristol-Myers Squibb, Forest Labs, Merck, Novartis, PDI Pharma, Pfizer
A Good Pharma Pick: Novartis
Seeking Alpha
Tue, 10/26/10 - 07:20 am
Tags:
Novartis, Alcon, Sanofi
Healthcare Fraud, Whistleblowers & US Treasury
Pharmalot
Mon, 10/25/10 - 10:37 am
Tags:
whistleblowers, healthcare fraud, Allergan, AstraZeneca, Novartis, Forest Labs, Elan, Teva Pharmaceuticals, JNJ
Novartis trial of meningococcal vaccine meets goal
Marketwatch
Mon, 10/25/10 - 09:04 am
Tags:
Novartis, vaccines, Menveo, meningococcal disease
Alcon names Novartis' Vasella as chairman
Marketwatch
Mon, 10/25/10 - 09:02 am
Tags:
Daniel Vasella, Novartis, Alcon, M&A
7 Big Pharma Stocks Near 52-Week Lows
Motley Fool
Sat, 10/23/10 - 12:44 pm
Tags:
JNJ, Novartis, GSK, Sanofi, Amgen, Teva Pharmaceuticals, Eli Lilly
7 Big Pharma Stocks Near 52-Week Lows
Motley Fool
Sat, 10/23/10 - 11:16 am
Tags:
JNJ, Novartis, GSK, Sanofi, Amgen, Teva Pharmaceuticals, Eli Lilly
The Top 10 Phase III Failures of 2010
Fierce Biotech
Fri, 10/22/10 - 11:36 am
Tags:
clinical trials, dimebon, Medivation, Pfizer, ocrelizumab, Roche, rheumatoid arthritis, taspoglutide, diabetes, Ipsen, semagacestat, Eli Lilly, ASA404, Antisoma, Novartis, Novelos Therapeutics, AstraZeneca, zibotentan, vicriviroc, Merck, Recentin, Vical, Sanofi
Novartis net income up 10%, driven by new products
Marketwatch
Thu, 10/21/10 - 10:49 am
Tags:
Novartis, earnings
Analyzing Major Big Pharma Players Using Relative Valuation
Seeking Alpha
Mon, 10/18/10 - 10:07 am
Tags:
Abbott Laboratories, Bristol-Myers Squibb, GSK, Eli Lilly, Merck, Novartis
GfK HealthCare Study: Physicians Ready to Accept New Oral Therapy for MS
Trading Markets
Sun, 10/17/10 - 11:54 am
Tags:
multiple sclerosis, Gilenya, Novartis
Bears Take a Big Dose of Novartis
Seeking Alpha
Wed, 10/13/10 - 04:08 pm
Tags:
Novartis
FDA warns of fractures with osteoporosis drugs
Yahoo/AP
Wed, 10/13/10 - 03:50 pm
Tags:
FDA, osteoporosis, Merck, biophosphonates, Boniva, warnings, Roche, Fosamax, Actonel, Novartis, Reclast, Warner Chilcott, Atelvia, P&G
10 Pharmaceutical Stocks With Up to 88% Upside
TheStreet.com
Tue, 10/12/10 - 11:01 am
Tags:
Novartis, Allergan, Shire, AstraZeneca, Abbott Laboratories, Merck, Pfizer, Teva Pharmaceuticals, Warner Chilcott, Valeant Pharmaceuticals
Novartis Paid Doc Who Urged Use of Seizure Meds on Bipolar Kids
BNET Pharma
Tue, 10/12/10 - 09:03 am
Tags:
physicial payments, Novartis, bipolar disorder Trileptal
TAP deal with Novartis brings ImmunoGen US$45 million upfront
Pharma Times, UK
Tue, 10/12/10 - 09:02 am
Tags:
TAP, Novartis, Immunogen
ImmunoGen climbs on cancer drug deal
Marketwatch
Mon, 10/11/10 - 11:22 am
Tags:
Immunogen, Novartis, cancer
Novartis Halts Development of Two Drugs: Biotech's Latest Tribulations
Seeking Alpha
Mon, 10/11/10 - 11:20 am
Tags:
Novartis, Actelion, AstraZeneca, Human Genome, JNJ, ONYX Pharmaceuticals, Pfizer, Rosetta Genomics, Targacept, Mycograb, albinterferon alfa-2b

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.